1. Taylor F, Ward K, Moore THM, Burke M, Smith GD, Casas JP, Ebrahim S (2012) Statins for the primary prevention of cardiovascular disease. Cochrane Database Syst Rev 1:2–8
2. Stone NJ, Robinson J, Lichtenstein AH, Bairey Merz CN, Lloyd-Jones DM, Blum CB, McBride PERH, Schwartz JS, Goldberg AC, Shero ST, Gordon D, Smith SC Jr, Levy D, Watson K, Wilson PWF (2014) 2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults. J Amer College Cardiol. doi: 10.1016/j.acc.2013.11.002
3. Hindler K, Cleeland CS, Rivera E, Collard CD (2006) The role of statins in cancer therapy. Oncologist 11:306–315
4. Elewa HF, El-Remessy AB, Somanath PR, Fagan SC (2010) Diverse effects of statins on angiogenesis: new therapeutic avenues. Pharmacotherapy 30:169–176
5. Bessoff K, Sateriale A, Lee KK, Huston CD (2013) Drug repurposing screen reveals FDA-approved inhibitors of human HMG-CoA reductase and isoprenoid synthesis that block Cryptosporidium parvum growth. Antimicrob Agents Chemother 57:1804–1814